f8k_080712.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  August 7, 2012
 
 
ROCKWELL MEDICAL, INC.
 
(Exact name of registrant as specified in its charter)
 
Michigan
  
000-23661
  
38-3317208
(State or other jurisdiction
  
(Commission
  
(IRS Employer
of incorporation)
  
File Number)
  
   Identification No.)
 
   30142 Wixom Road, Wixom, Michigan 48393
  (Address of principal executive offices)  (Zip Code)
     
 Registrant's telephone number, including area code     (248) 960-9009                                  
     
   
(F/K/A Rockwell Medical Technologies, Inc.)
  
  (Former name or former address, if changed since last report)  
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 

Item 2.02                      Results of Operations and Financial Condition.

On August 7, 2012, the Company issued the press release attached hereto as Exhibit 99.1, announcing its financial results for the quarter ended June 30, 2012.

Item 9.01                      Financial Statements and Exhibits.

The following exhibit is furnished with this Form 8-K:

Exhibit                                Description

 
99.1
Press Release dated August 7, 2012.


 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ROCKWELL MEDICAL, INC.


August 7, 2012                                                                By:           /S/ Thomas E. Klema                                                                
           Thomas E. Klema
                                                                                            Its: Chief Financial Officer

 
 
 

EXHIBIT INDEX

Exhibit                                           Description

99.1
Press Release dated August 7, 2012.